Tiered Pharmacy Copayments for Medications; Calendar Year 2020 Update, 11454-11455 [2020-03834]

Download as PDF 11454 Federal Register / Vol. 85, No. 39 / Thursday, February 27, 2020 / Notices as possible, and at least five business days prior to the event. SUPPLEMENTARY INFORMATION: Background: This is the third public hearing the Commission will hold during its 2020 report cycle. This hearing will assess the intentions behind China’s efforts to revise international governance institutions, norms and values, and technical standards-setting bodies. It will examine China’s vision for a revised global order, its actions in existing and newlyestablished international organizations to achieve its goals, and its attempts to promote new norms for the global digital economy. In so doing, the hearing will attempt to identify whether a distinguishable China model exists; if so, to what extent China is seeking to export it to other countries, and for what purpose; and the consequences of China’s growing influence in global governance and standards-setting bodies for U.S. interests. The hearing will be co-chaired by Senator Carte Goodwin and Senator Jim Talent. Any interested party may file a written statement by March 13, 2020 by mailing to the contact above. A portion of each panel will include a question and answer period between the Commissioners and the witnesses. Authority: Congress created the U.S.China Economic and Security Review Commission in 2000 in the National Defense Authorization Act Pub. L. 106– 398), as amended by Division P of the Consolidated Appropriations Resolution, 2003 (Pub. L. 108–7), as amended by Public Law 109–108 (November 22, 2005), as amended by Public Law 113–291 (December 19, 2014). Dated: February 24, 2020. Daniel W. Peck, Executive Director, U.S.-China Economic and Security Review Commission. [FR Doc. 2020–04035 Filed 2–26–20; 8:45 am] BILLING CODE 1137–00–P DEPARTMENT OF VETERANS AFFAIRS [OMB Control No. 2900–0178] lotter on DSKBCFDHB2PROD with NOTICES Agency Information Collection Activity: Monthly Certification of OnThe-Job and Apprenticeship Training Veterans Benefits Administration, Department of Veterans Affairs. ACTION: Notice. AGENCY: Veterans Benefits Administration, Department of Veterans Affairs (VA), is announcing an SUMMARY: VerDate Sep<11>2014 17:26 Feb 26, 2020 Jkt 250001 opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act (PRA) of 1995, Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed revision of a currently approved collection, and allow 60 days for public comment in response to the notice. DATES: Written comments and recommendations on the proposed collection of information should be received on or before April 27, 2020. ADDRESSES: Submit written comments on the collection of information through Federal Docket Management System (FDMS) at www.Regulations.gov or Danny S. Green, VA Clearance Officer, Office of Quality, Performance and Risk, Veterans Benefit Administration, Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC 20420 or email to Danny.Green2@ va.gov. Please refer to ‘‘OMB Control No. 2900–0178’’ in any correspondence. During the comment period, comments may be viewed online through FDMS. FOR FURTHER INFORMATION CONTACT: Danny S. Green at (202) 421–1354. SUPPLEMENTARY INFORMATION: Under the PRA of 1995, Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. This request for comment is being made pursuant to Section 3506(c)(2)(A) of the PRA. With respect to the following collection of information, VBA invites comments on: (1) Whether the proposed collection of information is necessary for the proper performance of VBA’s functions, including whether the information will have practical utility; (2) the accuracy of VBA’s estimate of the burden of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or the use of other forms of information technology. Authority: 38 U.S.C. 3680(c). Title: Monthly Certification of OnThe-Job and Apprenticeship Training, VA Form 22–6553d and VA Form 22– 6553d–1. OMB Control Number: 2900–0178. Type of Review: Revision of a currently approved collection. Abstract: Schools and training establishments complete the form to report whether the trainee’s number of PO 00000 Frm 00125 Fmt 4703 Sfmt 4703 hours worked and/or to report the trainee’s date of termination. VA Form 22–6553d–1 is an identical printed copy of VA Form 22–6553d. VA Form 22– 6553d–1 is used when the computergenerated version of VA Form 22–6553d is not available. VA uses the data collected to process a trainee’s educational benefit claim. Affected Public: Private Sector. Estimated Annual Burden: 5,693 hours. Estimated Average Burden per Respondent: 10 minutes. Frequency of Response: On occasion (9 responses per respondent annually). Estimated Number of Respondents: 3,795 (34,155 responses). By direction of the Secretary. Danny S. Green, VA Clearance Officer, Office of Quality, Performance and Risk, Department of Veterans Affairs. [FR Doc. 2020–03905 Filed 2–26–20; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Tiered Pharmacy Copayments for Medications; Calendar Year 2020 Update Department of Veterans Affairs. Notice. AGENCY: ACTION: This Department of Veterans Affairs (VA) Notice updates the information on Tier 1 medications. FOR FURTHER INFORMATION CONTACT: Joseph Duran, Office of Community Care (10D), Veterans Health Administration (VHA), Department of Veterans Affairs, Ptarmigan at Cherry Creek, Denver, CO 80209; Joseph.Duran2@va.gov; telephone: (303) 370–1637 (this is not a toll-free number). SUMMARY: Section 17.110 of Title 38 CFR governs copayments for medications that VA provides to Veterans. Section 17.110 provides the methodologies for establishing the copayment amount for each 30-day or less supply of medication provided by VA on an outpatient basis (other than medication administered during treatment). Tier 1 medication means a multisource medication that has been identified using the process described in paragraph (b)(2) of this section. Not less than once per year, VA will identify a subset of multi-source medications as Tier 1 medications. Only medications that meet all of the criteria in 38 CFR 17.110(b)(2)(i), (ii), and (iii) will be SUPPLEMENTARY INFORMATION: E:\FR\FM\27FEN1.SGM 27FEN1 Federal Register / Vol. 85, No. 39 / Thursday, February 27, 2020 / Notices eligible to be considered Tier 1 medications; and only those medications that meet all of the criteria in paragraph (b)(2)(i) of this section will be assessed using the criteria in paragraphs (b)(2)(ii) and (iii). Based on the methodologies set forth in § 17.110, this Notice updates the list of Tier 1 medications for Calendar Year 2020. The Tier 1 medication list is posted on VA’s Community Care website at: https://www.va.gov/ COMMUNITYCARE/revenue_ops/ 11455 copays.asp under the heading ‘‘Tier 1 Copay Medication List.’’ The following table is the Tier 1 Copay Medication List that is effective January 1, 2020 and will remain in effect until December 31, 2020. Condition VA product name Arthritis and Pain ......................... Aspirin Buffered Tablet, Aspirin Chewable Tablet, Aspirin Enteric Coated Tablet, Allopurinol Tablet, Celecoxib Capsule, Diclofenac Tablet, Ibuprofen Tablet, Meloxicam Tablet, Naproxen Tablet. Clopidogrel Bisulfate Tablet, Warfarin Sodium Tablet. Blood Thinners and Platelet Inhibitors. Bone Health ................................. Cholesterol .................................. Dementia ..................................... Diabetes ...................................... Dizziness (Vertigo) ...................... Electrolyte Supplement ............... Gastrointestinal Health ................ Glaucoma and Eye Care ............. Heart Health and Blood Pressure Mental Health .............................. Respiratory Condition .................. Seizures ....................................... Thyroid Conditions ...................... Urologic (Bladder and Prostate) Health. Alendronate Tablet. Atorvastatin Tablet, Gemfibrozil Tablet, Lovastatin Tablet, Pravastatin Tablet, Rosuvastatin Calcium Tablet, Simvastatin Tablet. Donepezil Tablet. Glimepiride Tablet, Glipizide Tablet, Metformin Hydrochloride (HCL) Tablet, Metformin HCL 24-hour Sustained Action (SA) Tablet, Pioglitazone HCL Tablet. Meclizine HCL Tablet, Meclizine HCL Chewable Tablet. Potassium SA Tablet, Potassium SA Dispersible Tablet. Omeprazole Enteric Coated (EC) Capsule, Pantoprazole Sodium EC Capsule, Ranitidine Tablet. Diclofenac 0.1% Solution, Dorzolamide 2%/Timolol 0.5% Solution, Latanoprost 0.005% Solution, PEG–400 0.4%/Propylene Glycol 0.3% Solution. Amlodipine Tablet, Amiodarone HCL Tablet, Aspirin (see Arthritis and Pain), Atenolol Tablet, Benazepril Tablet, Carvedilol Tablet, Chlorthalidone Tablet, Clonidine Tablet, Diltiazem 24-hour Capsule, Diltiazem HCL Tablet, Enalapril Maleate Tablet, Furosemide Tablet, Hydrochlorothiazide Capsule/Tablet, Hydrochlorothiazide/Lisinopril Tablet, Hydrochlorothiazide/Losartan Tablet, Hydrochlorothiazide/Triamterene Capsule/Tablet, Isosorbide Mononitrate SA Tablet, Lisinopril Tablet, Losartan Tablet, Metoprolol Succinate SA Tablet, Metoprolol Tartrate Tablet, Nifedipine SA Tablet, Nitroglycerin Sublingual Tablet, Prazosin HCL Capsule, Propranolol HCL Tablet, Spironolactone Tablet, Verapamil HCL Tablet, Verapamil HCL SA Tablet. Amitriptyline HCL Tablet, Bupropion HCL Tablet, Bupropion HCL SA (12HR–SR) Tablet, Bupropion HCL SA (24HR–XL) Tablet, Citalopram Hydrobromide Tablet, Duloxetine HCL EC Capsule, Escitalopram Oxalate Tablet, Fluoxetine Capsule/Tablet, Lithium Carbonate Capsule/Tablet, Mirtazapine Tablet, Paroxetine HCL Tablet, Sertraline HCL Tablet, Trazodone Tablet. Montelukast NA Tablet. Gabapentin Capsule/Tablet, Lamotrigine Tablet, Topiramate Tablet. Levothyroxine Sodium Tablet. Alfuzosin HCL SA Tablet, Doxazosin Mesylate Tablet, Finasteride Tablet, Sildenafil Tablet, Tamsulosin HCL Capsule, Terazosin HCL Capsule. Signing Authority The Secretary of Veterans Affairs, or designee, approved this document and authorized the undersigned to sign and submit the document to the Office of the Federal Register for publication electronically as an official document of the Department of Veterans Affairs. Pamela Powers, Chief of Staff, Department of Veterans Affairs, approved this document on February 19, 2020, for publication. Luvenia Potts, Regulation Development Coordinator, Office of Regulation Policy & Management, Office of the Secretary, Department of Veterans Affairs. [FR Doc. 2020–03834 Filed 2–26–20; 8:45 am] lotter on DSKBCFDHB2PROD with NOTICES BILLING CODE 8320–01–P VerDate Sep<11>2014 17:26 Feb 26, 2020 Jkt 250001 PO 00000 Frm 00126 Fmt 4703 Sfmt 9990 E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 85, Number 39 (Thursday, February 27, 2020)]
[Notices]
[Pages 11454-11455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03834]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Tiered Pharmacy Copayments for Medications; Calendar Year 2020 
Update

AGENCY: Department of Veterans Affairs.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This Department of Veterans Affairs (VA) Notice updates the 
information on Tier 1 medications.

FOR FURTHER INFORMATION CONTACT: Joseph Duran, Office of Community Care 
(10D), Veterans Health Administration (VHA), Department of Veterans 
Affairs, Ptarmigan at Cherry Creek, Denver, CO 80209; 
[email protected]; telephone: (303) 370-1637 (this is not a toll-
free number).

SUPPLEMENTARY INFORMATION: Section 17.110 of Title 38 CFR governs 
copayments for medications that VA provides to Veterans. Section 17.110 
provides the methodologies for establishing the copayment amount for 
each 30-day or less supply of medication provided by VA on an 
outpatient basis (other than medication administered during treatment).
    Tier 1 medication means a multi-source medication that has been 
identified using the process described in paragraph (b)(2) of this 
section. Not less than once per year, VA will identify a subset of 
multi-source medications as Tier 1 medications. Only medications that 
meet all of the criteria in 38 CFR 17.110(b)(2)(i), (ii), and (iii) 
will be

[[Page 11455]]

eligible to be considered Tier 1 medications; and only those 
medications that meet all of the criteria in paragraph (b)(2)(i) of 
this section will be assessed using the criteria in paragraphs 
(b)(2)(ii) and (iii).
    Based on the methodologies set forth in Sec.  17.110, this Notice 
updates the list of Tier 1 medications for Calendar Year 2020. The Tier 
1 medication list is posted on VA's Community Care website at: https://www.va.gov/COMMUNITYCARE/revenue_ops/copays.asp under the heading 
``Tier 1 Copay Medication List.''
    The following table is the Tier 1 Copay Medication List that is 
effective January 1, 2020 and will remain in effect until December 31, 
2020.

------------------------------------------------------------------------
                  Condition                         VA product name
------------------------------------------------------------------------
Arthritis and Pain...........................  Aspirin Buffered Tablet,
                                                Aspirin Chewable Tablet,
                                                Aspirin Enteric Coated
                                                Tablet, Allopurinol
                                                Tablet, Celecoxib
                                                Capsule, Diclofenac
                                                Tablet, Ibuprofen
                                                Tablet, Meloxicam
                                                Tablet, Naproxen Tablet.
Blood Thinners and Platelet Inhibitors.......  Clopidogrel Bisulfate
                                                Tablet, Warfarin Sodium
                                                Tablet.
Bone Health..................................  Alendronate Tablet.
Cholesterol..................................  Atorvastatin Tablet,
                                                Gemfibrozil Tablet,
                                                Lovastatin Tablet,
                                                Pravastatin Tablet,
                                                Rosuvastatin Calcium
                                                Tablet, Simvastatin
                                                Tablet.
Dementia.....................................  Donepezil Tablet.
Diabetes.....................................  Glimepiride Tablet,
                                                Glipizide Tablet,
                                                Metformin Hydrochloride
                                                (HCL) Tablet, Metformin
                                                HCL 24-hour Sustained
                                                Action (SA) Tablet,
                                                Pioglitazone HCL Tablet.
Dizziness (Vertigo)..........................  Meclizine HCL Tablet,
                                                Meclizine HCL Chewable
                                                Tablet.
Electrolyte Supplement.......................  Potassium SA Tablet,
                                                Potassium SA Dispersible
                                                Tablet.
Gastrointestinal Health......................  Omeprazole Enteric Coated
                                                (EC) Capsule,
                                                Pantoprazole Sodium EC
                                                Capsule, Ranitidine
                                                Tablet.
Glaucoma and Eye Care........................  Diclofenac 0.1% Solution,
                                                Dorzolamide 2%/Timolol
                                                0.5% Solution,
                                                Latanoprost 0.005%
                                                Solution, PEG-400 0.4%/
                                                Propylene Glycol 0.3%
                                                Solution.
Heart Health and Blood Pressure..............  Amlodipine Tablet,
                                                Amiodarone HCL Tablet,
                                                Aspirin (see Arthritis
                                                and Pain), Atenolol
                                                Tablet, Benazepril
                                                Tablet, Carvedilol
                                                Tablet, Chlorthalidone
                                                Tablet, Clonidine
                                                Tablet, Diltiazem 24-
                                                hour Capsule, Diltiazem
                                                HCL Tablet, Enalapril
                                                Maleate Tablet,
                                                Furosemide Tablet,
                                                Hydrochlorothiazide
                                                Capsule/Tablet,
                                                Hydrochlorothiazide/
                                                Lisinopril Tablet,
                                                Hydrochlorothiazide/
                                                Losartan Tablet,
                                                Hydrochlorothiazide/
                                                Triamterene Capsule/
                                                Tablet, Isosorbide
                                                Mononitrate SA Tablet,
                                                Lisinopril Tablet,
                                                Losartan Tablet,
                                                Metoprolol Succinate SA
                                                Tablet, Metoprolol
                                                Tartrate Tablet,
                                                Nifedipine SA Tablet,
                                                Nitroglycerin Sublingual
                                                Tablet, Prazosin HCL
                                                Capsule, Propranolol HCL
                                                Tablet, Spironolactone
                                                Tablet, Verapamil HCL
                                                Tablet, Verapamil HCL SA
                                                Tablet.
Mental Health................................  Amitriptyline HCL Tablet,
                                                Bupropion HCL Tablet,
                                                Bupropion HCL SA (12HR-
                                                SR) Tablet, Bupropion
                                                HCL SA (24HR-XL) Tablet,
                                                Citalopram Hydrobromide
                                                Tablet, Duloxetine HCL
                                                EC Capsule, Escitalopram
                                                Oxalate Tablet,
                                                Fluoxetine Capsule/
                                                Tablet, Lithium
                                                Carbonate Capsule/
                                                Tablet, Mirtazapine
                                                Tablet, Paroxetine HCL
                                                Tablet, Sertraline HCL
                                                Tablet, Trazodone
                                                Tablet.
Respiratory Condition........................  Montelukast NA Tablet.
Seizures.....................................  Gabapentin Capsule/
                                                Tablet, Lamotrigine
                                                Tablet, Topiramate
                                                Tablet.
Thyroid Conditions...........................  Levothyroxine Sodium
                                                Tablet.
Urologic (Bladder and Prostate) Health.......  Alfuzosin HCL SA Tablet,
                                                Doxazosin Mesylate
                                                Tablet, Finasteride
                                                Tablet, Sildenafil
                                                Tablet, Tamsulosin HCL
                                                Capsule, Terazosin HCL
                                                Capsule.
------------------------------------------------------------------------

Signing Authority

    The Secretary of Veterans Affairs, or designee, approved this 
document and authorized the undersigned to sign and submit the document 
to the Office of the Federal Register for publication electronically as 
an official document of the Department of Veterans Affairs. Pamela 
Powers, Chief of Staff, Department of Veterans Affairs, approved this 
document on February 19, 2020, for publication.

Luvenia Potts,
Regulation Development Coordinator, Office of Regulation Policy & 
Management, Office of the Secretary, Department of Veterans Affairs.
[FR Doc. 2020-03834 Filed 2-26-20; 8:45 am]
BILLING CODE 8320-01-P